Literature DB >> 870429

Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.

M Rogolsky, B B Wiley.   

Abstract

Previous data from this laboratory showed that certain phage group 2 staphylococci contain a large 56S virulence plasmid containing genes that code for both exfoliative toxin (ET) and a specific staphylococcin. Optimal cultural conditions for bacteriocin production were similar to those found for ET production. The bacteriocin is an extracellular product produced in small quantities that can be neither extracted from cell pellets with 1 M NaCl nor induced with mitomycin C. The staphylococcin is active against a wide variety of gram-positive organisms and also against group 2 staphylococcal strains that have been cured of the plasmid carrying the staphylococcin marker. The bacteriocin is not inactivated by oxidation, mechanical agitation, or boiling for 15 min. It is sensitive to the action of trypsin and Pronase but not lysostaphin and is stable within a pH range of 4 to 9. It has an isoelectric point of approximately 7.7. Removal of the ampholytes and glycerol from electrofocused staphylococcin preparations resulted in total loss of bacteriocin activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870429      PMCID: PMC421430          DOI: 10.1128/iai.15.3.726-732.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production.

Authors:  M Rogolsky; B B Wiley; L A Glasgow
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

2.  Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus.

Authors:  R Warren; M Rogolsky; B B Wiley; L A Glasgow
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

3.  Purification and characterization of a staphylococcal epidermolytic toxin.

Authors:  R L Dimond; K D Wuepper
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

4.  Production, purification, and chemical characterization of Staphylococcus aureus exfoliative toxin.

Authors:  A D Johnson; J F Metzger; L Spero
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

5.  Staphylococcal scalded-skin syndrome: development of a primary binding assay for human antibody to the exfoliative toxin.

Authors:  B B Wiley; L A Glasgow; M Rogolsky
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  Demonstration of a bactericidal substance against beta-hemolytic streptococci in supernatant fluids of staphylococcal cultures.

Authors:  A S Dajani; L W Wannamaker
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

7.  Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus.

Authors:  M Rogolsky; R Warren; B B Wiley; H T Nakamura; L A Glasgow
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

8.  Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.

Authors:  I Kondo; S Sakurai; Y Sarai
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

9.  Staphylococcal scalded skin syndrome: the expanded clinical syndrome.

Authors:  M E Melish; L A Glasgow
Journal:  J Pediatr       Date:  1971-06       Impact factor: 4.406

Review 10.  Bacteriocins of gram-positive bacteria.

Authors:  J R Tagg; A S Dajani; L W Wannamaker
Journal:  Bacteriol Rev       Date:  1976-09
View more
  11 in total

Review 1.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

2.  Transfer of the plasmid for exfoliative toxin B synthesis in mixed cultures on nitrocellulose membranes.

Authors:  M Rogolsky; B W Beall; B B Wiley
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

3.  Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from gram-positive bacteria.

Authors:  H G Sahl
Journal:  Appl Environ Microbiol       Date:  1994-02       Impact factor: 4.792

4.  Cloning and expression of cadD, a new cadmium resistance gene of Staphylococcus aureus.

Authors:  S S Crupper; V Worrell; G C Stewart; J J Iandolo
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

5.  Exfoliative toxin plasmids of bacteriophage group 2 Staphylococcus aureus: sequence homology.

Authors:  R L Warren
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Mutagenesis of extrachromosomal genetic determinants for exfoliative toxin B and bacteriocin R1 synthesis in Staphylococcus aureus after plasmid transfer by protoplast fusion.

Authors:  R Masterson; W von David; B B Wiley; M Rogolsky
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55.

Authors:  M A Navaratna; H G Sahl; J R Tagg
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

8.  Purification and characterization of staphylococcin BacR1, a broad-spectrum bacteriocin.

Authors:  S S Crupper; A J Gies; J J Iandolo
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

9.  Genetic mapping in phage group 2 Staphylococcus aureus.

Authors:  S M Martin; S C Shoham; M Alsup; M Rogolsky
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Purification and partial characterization of a novel antibacterial agent (Bac1829) Produced by Staphylococcus aureus KSI1829.

Authors:  S S Crupper; J J Iandolo
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.